TIL Instil Bio, Inc. - Common Stock
$7,38
Preço · Ago 14, 2026
Fundamentais a partir de Ago 13, 2026
Intervalo 52 Semanas
$6–$34
6% of range
Classificação do Analista
BUY
7 analysts
Preço-Alvo
$7
P/E (TTM)
-0.7
ROE
-58.1%
Margem de Lucro Líquido
—
TIL Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$7.38
Capitalização de Mercado
$50M
P/E (TTM)
-0.7
EPS (TTM)
$-10.70
Receita (TTM)
—
Rendimento div.
—
ROE
-58.1%
Dívida/Capital
—
Intervalo 52 Semanas
$6 – $34
TIL Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
—
2020-12-31
→
2021-12-31
EPS
$-10.70
2020-12-31
→
2025-12-31
Fluxo de caixa livre
—
2021-12-31
→
2024-12-31
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
TIL
Mediana de Pares
P/E (TTM)
-0.7
—
P/S (TTM)
962.5
4.1
P/B
0.4
1.4
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
TIL
Mediana de Pares
ROA
-30.6%
-101.8%
ROE
-58.1%
-136.1%
ROIC
-69.0%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
TIL
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
39.5
3.0
Quick Ratio (Índice de Liquidez Seca)
1.4
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
TIL
Mediana de Pares
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
TIL
Mediana de Pares
TIL Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
7 analistas
- Compra forte 2 28,6%
- Compra 3 42,9%
- Manter 2 28,6%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
1 analistas · 2026-08-16
Mín
$7.00
Máx
$7.00
Alvo mediano
$7.00
-5,1%
Alvo médio
$7.00
-5,1%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.03%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-0.62 | $-0.60 | -0.02% |
| 31 de Dezembro de 2025 | $-1.21 | $-2.05 | 0.84% |
| 30 de Setembro de 2025 | $-2.01 | $-2.38 | 0.37% |
| 30 de Junho de 2025 | $-3.24 | $-2.53 | -0.71% |
| 31 de Março de 2025 | $-4.32 | $-2.61 | -1.7% |
| 31 de Dezembro de 2024 | $-1.82 | $-3.25 | 1.4% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| TIL | $75M | -1.0 | — | — | -58.1% | — |
| TCRX | — | -1.0 | 266.7% | -1256.8% | -86.6% | — |
| APLM | — | — | — | — | — | — |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | — |
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | — |
| MCRB | $142M | 23.2 | — | 721.9% | 14.8% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | $138.0K | |
| R&D Expense | · | · | $40M | $141M | $107M | $19M | |
| SG&A Expense | $27M | $44M | $48M | $62M | $48M | $14M | |
| Operating Expenses | $79M | $74M | $159M | $226M | $156M | $34M | |
| Operating Income | $-79M | $-74M | $-159M | $-226M | $-156M | $-34M | |
| Interest Expense | · | · | $5M | $2M | $0 | · | |
| Other Non-op | $212.0K | $-3M | $-575.0K | $-564.0K | $-1M | $-4M | |
| Pretax Income | $-71M | $-74M | $-156M | $-225M | $-157M | $-38M | |
| Income Tax | $0 | · | $0 | $-2M | $39.0K | $151.0K | |
| Net Income | $-71M | $-74M | $-156M | $-223M | $-157M | $-38M | |
| EPS (Basic) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| EPS (Diluted) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| Shares (Basic) | 6,668,268 | 6,510,138 | 6,503,913 | 6,475,631 | 105,993,230 | 15,997,794 | |
| Shares (Diluted) | 6,668,268 | 6,510,138 | 6,503,913 | 6,475,631 | 105,993,230 | 15,997,794 | |
| EBITDA | $-78M | $-70M | $-154M | $-220M | $-153M | · |
Balanço Patrimonial 24
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $9M | $44M | $38M | $242M | |
| Short-term Investments | · | · | $141M | $217M | $417M | $0 | |
| Prepaid Expense | $3M | $9M | $9M | $8M | $10M | $4M | |
| Other Current Assets | $148.0K | $959.0K | $3M | · | · | $70.0K | |
| Current Assets | $191M | $124M | $161M | $269M | $464M | $246M | |
| PP&E (Net) | $126.0K | $129M | $139M | $197M | $122M | $55M | |
| PP&E (Gross) | $509.0K | $134M | $146M | $205M | $125M | $56M | |
| Accum. Depreciation | $383.0K | $5M | $8M | $8M | $3M | $306.0K | |
| Goodwill | · | · | · | $0 | $6M | $6M | |
| Other Non-current Assets | $4M | $4M | $639.0K | $3M | $8M | $2M | |
| Total Assets | $204M | $264M | $326M | $482M | $610M | $319M | |
| Accounts Payable | $779.0K | $659.0K | $1M | $2M | $6M | $3M | |
| Current Liabilities | $5M | $8M | $11M | $33M | $41M | $13M | |
| Capital Leases | $0 | $1M | $3M | $5M | $0 | · | |
| Deferred Tax | · | · | · | $0 | $2M | $2M | |
| Other Non-current Liabilities | $8.0K | $83.0K | $80.0K | $332.0K | $20.0K | $0 | |
| Total Liabilities | $90M | $94M | $100M | $119M | $55M | $27M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $841M | $825M | $807M | $789M | $757M | $6M | |
| Retained Earnings | $-726M | $-655M | $-581M | $-425M | $-202M | $-45M | |
| AOCI | $-583.0K | $-228.0K | $-348.0K | $-493.0K | $-87.0K | $-283.0K | |
| Stockholders' Equity | $114M | $169M | $226M | $364M | $555M | $-40M | |
| Liabilities + Equity | $204M | $264M | $326M | $482M | $610M | $319M | |
| Shares Outstanding | 6,781,976 | 6,525,887 | 6,503,913 | 6,503,913 | 6,451,463 | 20,591,554 |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $534.0K | $4M | $5M | $6M | $3M | $256.0K | |
| Stock-based Comp | $9M | $17M | $18M | $30M | $26M | $2M | |
| Deferred Tax | · | · | $0 | $-2M | $39.0K | $267.0K | |
| Other Non-cash | $26M | $-2M | $51M | $9M | $6M | · | |
| Operating Cash Flow | $-37M | $-56M | $-82M | $-180M | $-122M | $-30M | |
| CapEx | · | $0 | $21M | $85M | $58M | $51M | |
| Investing Cash Flow | $25M | $54M | $41M | $115M | $-474M | $-51M | |
| Stock Issued | $7M | $0 | · | · | · | · | |
| Net Stock Activity | $7M | · | · | · | · | · | |
| Financing Cash Flow | $7M | $2M | $8M | $72M | $393M | $313M | |
| Free Cash Flow | · | $-56M | $-103M | $-265M | $-180M | · | |
| Levered FCF | · | · | $-108M | $-267M | · | · |
Lucratividade 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -30.6% | -25.2% | -38.6% | -40.9% | -33.8% | · | |
| ROE | -58.1% | -42.9% | -67.9% | -57.6% | -27.1% | · | |
| ROIC | -69.0% | · | -70.5% | -61.7% | -28.0% | · |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 39.5 | 15.8 | 15.2 | 8.2 | 11.2 | · | |
| Quick Ratio | 1.4 | 1.1 | 14.2 | 8.0 | 11.0 | · | |
| Interest Coverage | · | · | -30.6 | -120.3 | · | · |
Eficiência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $52.0K | $52.0K | $52.0K | $52.0K | $0 | · | |
| Net Income TTM | $-71M | $-74M | $-156M | $-223M | $-157M | · | |
| Market Cap | $75M | $125M | $50M | $1.64B | $44.15B | · | |
| P/E | -1.0 | -1.7 | -0.3 | -0.4 | -231.2 | · | |
| P/S | 1434.6 | 2395.8 | 953.1 | 31519.2 | · | · | |
| P/B | 0.7 | 0.7 | 0.2 | 4.5 | 79.5 | · | |
| P / Tangible Book | 0.7 | 0.7 | 0.2 | 4.5 | 80.4 | · | |
| P / Cash Flow | -2.0 | -2.2 | -0.6 | -9.1 | -361.5 | · | |
| P / FCF | · | -2.2 | -0.5 | -6.2 | -245.3 | · | |
| Earnings Yield | -97.3% | -59.7% | -315.0% | -273.5% | -0.43% | · |
Demonstração de Resultados 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | $3M | $7M | · | $8M | $8M | $21M | $21M | $40M | |
| SG&A Expense | $5M | $5M | $6M | $6M | $6M | $9M | $10M | $11M | $11M | $12M | $11M | $12M | $12M | $13M | $13M | $17M | |
| Operating Expenses | $6M | $7M | $10M | $15M | $23M | $31M | $12M | $24M | $14M | $24M | $13M | $67M | $21M | $58M | $57M | $57M | |
| Operating Income | $-6M | $-7M | $-10M | $-15M | $-23M | $-31M | $-12M | $-24M | $-14M | $-24M | $-13M | $-67M | $-21M | $-58M | $-57M | $-57M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $2M | $590.0K | $636.0K | $745.0K | $807.0K | |
| Other Non-op | $-10.0K | $-182.0K | $-55.0K | $-118.0K | $342.0K | $43.0K | $-1M | $-530.0K | $-702.0K | $-428.0K | $-120.0K | $-1M | $628.0K | $-57.0K | $1M | $-415.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-13M | $-67M | $-19M | $-57M | $-54M | $-57M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-605.0K | $-371.0K | |
| Net Income | $-4M | $-4M | $-8M | $-14M | $-21M | $-28M | $-12M | $-23M | $-15M | $-24M | $-13M | $-67M | $-19M | $-57M | $-54M | $-56M | |
| EPS (Basic) | $-0.63 | $-0.62 | $-1.13 | $-2.01 | $-3.24 | $-4.32 | $-1.82 | $-3.54 | $-2.29 | $-3.74 | $-1.99 | $-10.37 | $-2.87 | $-8.77 | $-33.15 | $-0.43 | |
| EPS (Diluted) | $-0.63 | $-0.62 | $-1.13 | $-2.01 | $-3.24 | $-4.32 | $-1.82 | $-3.54 | $-2.29 | $-3.74 | $-1.99 | $-10.37 | $-2.87 | $-8.77 | $-33.15 | $-0.43 | |
| Shares (Basic) | 6,781,976 | 6,781,976 | -13,219,107 | 6,757,742 | 6,596,975 | 6,532,658 | -13,004,369 | 6,506,681 | 6,503,913 | 6,503,913 | -13,007,826 | 6,503,913 | 6,503,913 | 6,503,913 | -381,691,881 | 129,680,217 | |
| Shares (Diluted) | 6,781,976 | 6,781,976 | -13,219,107 | 6,757,742 | 6,596,975 | 6,532,658 | -13,004,369 | 6,506,681 | 6,503,913 | 6,503,913 | -13,007,826 | 6,503,913 | 6,503,913 | 6,503,913 | -381,691,881 | 129,680,217 | |
| EBITDA | $-6M | $-7M | · | $-15M | $-23M | $-30M | · | $-24M | $-14M | $-23M | · | $-67M | $-21M | $-57M | · | $-57M |
Balanço Patrimonial 24
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $5M | $7M | $6M | $8M | $15M | $9M | $7M | $7M | $5M | $9M | $9M | $22M | $27M | $44M | $41M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $174M | $180M | $196M | $217M | $262M | |
| Prepaid Expense | $2M | $2M | $3M | $4M | $3M | $3M | $9M | $12M | $6M | $6M | $9M | $11M | $12M | $9M | $8M | $10M | |
| Other Current Assets | $76.0K | $143.0K | $148.0K | $164.0K | $154.0K | $192.0K | $959.0K | $2M | · | · | $3M | · | · | · | · | · | |
| Current Assets | $72M | $188M | $191M | $196M | $207M | $219M | $124M | $133M | $155M | $161M | $161M | $196M | $221M | $240M | $269M | $314M | |
| PP&E (Net) | $112M | $112.0K | $126.0K | $138.0K | $150.0K | $162.0K | $129M | $130M | $133M | $134M | $139M | $139M | $181M | $180M | $197M | $185M | |
| PP&E (Gross) | $112M | · | $509.0K | $509.0K | $509.0K | $509.0K | $134M | $134M | $138M | $138M | $146M | $146M | $187M | $185M | $205M | $191M | |
| Accum. Depreciation | $638.0K | $389.0K | $383.0K | $371.0K | $359.0K | $347.0K | $5M | $4M | $5M | $4M | $8M | $6M | $6M | $5M | $8M | $6M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $11M | $10M | $4M | $6M | $581.0K | $2M | $639.0K | $3M | $3M | $4M | $3M | $5M | |
| Total Assets | $198M | $200M | $204M | $212M | $231M | $237M | $264M | $273M | $294M | $306M | $326M | $340M | $408M | $427M | $482M | $533M | |
| Accounts Payable | $795.0K | $793.0K | $779.0K | $928.0K | $523.0K | $286.0K | $659.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $5M | |
| Current Liabilities | $3M | $5M | $5M | $6M | $14M | $7M | $8M | $10M | $10M | $11M | $11M | $13M | $18M | $27M | $33M | $42M | |
| Capital Leases | $2M | · | $0 | $0 | $6.0K | $48.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $555.0K | |
| Other Non-current Liabilities | $0 | $8.0K | $8.0K | $88.0K | $90.0K | $85.0K | $83.0K | $8.0K | $8.0K | $43.0K | $80.0K | $115.0K | $162.0K | $196.0K | $332.0K | $375.0K | |
| Total Liabilities | $90M | $90M | $90M | $91M | $99M | $93M | $94M | $96M | $99M | $100M | $100M | $106M | $112M | $116M | $119M | $122M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $843M | $842M | $841M | $839M | $837M | $829M | $825M | $820M | $816M | $812M | $807M | $803M | $798M | $794M | $789M | $782M | |
| Retained Earnings | $-735M | $-731M | $-726M | $-718M | $-705M | $-683M | $-655M | $-643M | $-620M | $-605M | $-581M | $-568M | $-501M | $-482M | $-425M | $-371M | |
| AOCI | $-587.0K | $-532.0K | $-583.0K | $-612.0K | $-805.0K | $-451.0K | $-228.0K | $-520.0K | $-627.0K | $-563.0K | $-348.0K | $-525.0K | $-795.0K | $-406.0K | $-493.0K | $-335.0K | |
| Stockholders' Equity | $107M | $111M | $114M | $120M | $132M | $145M | $169M | $176M | $195M | $206M | $226M | $234M | $297M | $311M | $364M | $411M | |
| Liabilities + Equity | $198M | $200M | $204M | $212M | $231M | $237M | $264M | $273M | $294M | $306M | $326M | $340M | $408M | $427M | $482M | $533M | |
| Shares Outstanding | 6,781,976 | 6,781,976 | 6,781,976 | 6,781,976 | 6,750,716 | 6,558,927 | 6,525,887 | 6,525,266 | 6,503,913 | 6,503,913 | 6,503,913 | 130,079,097 | 130,079,097 | 130,079,097 | 6,503,913 | 129,753,672 |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $248.0K | $12.0K | $12.0K | $12.0K | $12.0K | $498.0K | $741.0K | $901.0K | $975.0K | $993.0K | $1M | $953.0K | $991.0K | $2M | $2M | $2M | |
| Stock-based Comp | $1M | $985.0K | $2M | $2M | $2M | $3M | $5M | $4M | $4M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | |
| Other Non-cash | · | $2M | · | · | · | $20M | · | · | · | $4M | · | · | · | $16M | · | · | |
| Operating Cash Flow | $-5M | $-1M | $-7M | $-11M | $-15M | $-4M | $-11M | $-20M | $-11M | $-14M | $-13M | $-14M | $-20M | $-35M | $-37M | $-41M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $58.0K | $5M | $7M | $8M | $13M | $25M | |
| Investing Cash Flow | $5M | $-317.0K | $8M | $8M | $-400.0K | $10M | $13M | $20M | $12M | $9M | $14M | $2M | $10M | $15M | $33M | $25M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $0 | $0 | $378.0K | $7M | $232.0K | $2M | $159.0K | $0 | $0 | $0 | $-587.0K | $4M | $4M | $6M | $15M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-43M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-44M | · | · |
Lucratividade 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -2.0% | -1.9% | · | -5.6% | -8.2% | -10.4% | · | -7.5% | -4.2% | -6.6% | · | -15.4% | -3.8% | -11.5% | · | -9.5% | |
| ROE | -3.6% | -3.3% | · | -9.2% | -13.1% | -16.1% | · | -11.2% | -6.1% | -9.4% | · | -20.9% | -4.9% | -13.9% | · | -11.1% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | -28.5% | -7.1% | -18.8% | · | -13.7% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | 39.9 | · | 34.5 | 15.0 | 30.3 | · | 12.9 | 15.1 | 14.2 | · | 14.5 | 12.0 | 9.0 | · | 7.5 | |
| Quick Ratio | 1.7 | 1.1 | · | 1.0 | 0.6 | 2.1 | · | 0.6 | 0.7 | 0.5 | · | 13.6 | 11.0 | 8.4 | · | 7.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -12.1 | · | -33.3 | -35.6 | -91.9 | · | -70.2 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $52.0K | $52.0K | · | $52.0K | $52.0K | $52.0K | · | $52.0K | $52.0K | $52.0K | · | $52.0K | $52.0K | $52.0K | · | $52.0K | |
| Net Income TTM | $-43M | $-67M | · | $-86M | $-88M | $-90M | · | $-130M | $-125M | $-167M | · | $-199M | $-191M | $-226M | · | $-212M | |
| Market Cap | $52M | $56M | · | $121M | $141M | $114M | · | $439M | $67M | $70M | · | $1.11B | $1.43B | $1.72B | · | $12.56B | |
| P/E | -1.2 | -0.8 | · | -1.4 | -1.6 | -1.2 | · | -3.4 | -0.5 | -0.4 | · | -0.4 | -0.9 | -1.3 | · | -59.0 | |
| P/S | 1002.9 | 1074.7 | · | 2329.3 | 2704.2 | 2189.7 | · | 8447.7 | 1287.0 | 1350.8 | · | 21413.0 | 27566.8 | 33070.1 | · | 241541.5 | |
| P/B | 0.5 | 0.5 | · | 1.0 | 1.1 | 0.8 | · | 2.5 | 0.3 | 0.3 | · | 4.8 | 4.8 | 5.5 | · | 30.6 | |
| P / Tangible Book | 0.5 | 0.5 | · | 1.0 | 1.1 | 0.8 | · | 2.5 | 0.3 | 0.3 | · | 4.8 | 4.8 | 5.5 | · | 31.0 | |
| P / Cash Flow | · | -41.8 | · | · | · | -27.1 | · | · | · | -4.9 | · | · | · | -49.6 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -39.9 | · | · | |
| Earnings Yield | -84.5% | -123.7% | · | -73.4% | -64.3% | -80.0% | · | -29.6% | -187.3% | -238.4% | · | -262.2% | -113.7% | -76.2% | · | -1.7% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | — | — | — | — | $0 |
| Lucro líquido | $-71M | $-74M | $-156M | $-223M | $-157M |
| EPS Diluído | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 39.5 | 15.8 | 15.2 | 8.2 | 11.2 |
| Índice de Liquidez Seca | 1.4 | 1.1 | 14.2 | 8.0 | 11.0 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | — | $-56M | $-103M | $-265M | $-180M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 31 declarantes · $34.3M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 8 (+1 vs trimestre anterior) | 10 (+5 vs trimestre anterior) | 3 (-1 vs trimestre anterior) | 7 (-1 vs trimestre anterior) | -188K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Curative Ventures V LLC | $14.603.341 | 1.899.004 | 42,55% | Ações |
| BML Capital Management, LLC | $4.964.664 | 645.600 | 14,46% | Ações |
| CPMG Inc | $3.385.997 | 410.922 | 9,87% | Ações |
| Vivo Capital, LLC | $2.251.194 | 292.743 | 6,56% | Ações |
| VANGUARD GROUP INC | $1.836.615 | 166.965 | 5,35% | Ações |
| UBS Group AG | $1.330.116 | 172.967 | 3,88% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.259.145 | 163.738 | 3,67% | Ações |
| MILLENNIUM MANAGEMENT LLC | $1.034.882 | 134.575 | 3,02% | Ações |
| Kalehua Capital Management LLC | $765.924 | 99.600 | 2,23% | Ações |
| AlphaQuest LLC | $410.069 | 37.279 | 1,19% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $386.807 | 50.300 | 1,13% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $385.000 | 50.000 | 1,12% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $331.062 | 43.051 | 0,96% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $262.496 | 34.116 | 0,76% | Ações |
| LPL Financial LLC | $246.653 | 32.075 | 0,72% | Ações |
| CITADEL ADVISORS LLC | $235.614 | 30.639 | 0,69% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $175.124 | 22.773 | 0,51% | Ações |
| STATE STREET CORP | $135.306 | 17.595 | 0,39% | Ações |
| Americana Partners, LLC | $124.393 | 16.176 | 0,36% | Ações |
| Pinpoint Asset Management Ltd | $88.432 | 5.094 | 0,26% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $83.790 | 10.896 | 0,24% | Ações |
| Vanguard Global Advisers, LLC | $11.304 | 1.470 | 0,03% | Ações |
| BlackRock, Inc. | $5.583 | 726 | 0,02% | Ações |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $4.230 | 550 | 0,01% | Ações |
| MORGAN STANLEY | $1.846 | 240 | 0,01% | Ações |
| Lindbrook Capital, LLC | $1.180 | 68 | 0,00% | Ações |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $961 | 125 | 0,00% | Ações |
| CITIGROUP INC | $677 | 88 | 0,00% | Ações |
| Tower Research Capital LLC (TRC) | $246 | 32 | 0,00% | Ações |
| BARCLAYS PLC | $223 | 29 | 0,00% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $54 | 7 | 0,00% | Ações |
Executivos da empresa 11 insiders · 3 diretores · 7 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Bronson Crouch | CEO and Chairman | 23 de Março de 2021 C | 37.980.073 | 0 | 0 | $0 |
| Sandeep Laumas | CFO and CBO | 18 de Março de 2021 A | — | 0 | 0 | $0 |
| Zachary Roberts | Chief Medical Officer | 18 de Março de 2021 A | — | 0 | 0 | $0 |
| George Matcham | Conselheiro | 11 de Junho de 2026 A | — | 0 | 0 | $0 |
| Gwendolyn Binder | Conselheiro | 11 de Junho de 2026 A | — | 0 | 0 | $0 |
| Neil W Gibson | Conselheiro | 11 de Junho de 2026 A | — | 0 | 0 | $0 |
| Kent R Mcgaughy Jr | Conselheiro | 11 de Junho de 2026 A | 8.478.790 | 0 | 0 | $0 |
| Nimish P Shah | Conselheiro | 23 de Março de 2021 C | 19.620 | 0 | 0 | $0 |
| Jack Nielsen | Conselheiro | 23 de Março de 2021 C | 12.486.787 | 0 | 0 | $0 |
| Curative Ventures V LLC | Detentor de 10% | 23 de Março de 2021 C | 37.980.073 | 0 | 0 | $0 |
| Vijay Chiruvolu | — | 18 de Março de 2021 A | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Curative Ventures V LLC, CV-Immetacyte Manager LP, CV-Immetacyte Ultimate Manager LLC, SB2A LP, SB2A Management LLC, Bronson Crouch, Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power CVV 0 37,980,073 0 37,980,073 CV-Immetacyte Manager 0 37,980,073 0 37,980,073 Ultimate Manager 0 37,980,073 0 37,980,073 SB2A 0 40,380,072 0 40,380,072 SB2A Manager 0 40, Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power CVV 0 1,899,003 0 1,899,003 CV-Immetacyte Manager 0 1,899,003 0 1,899,003 Ultimate Manager 0 1,899,003 0 1,899,003 SB2A 0 2,019,002 0 2,019,002 SB2A Manager 0 2,019,002 ×2 declarações | 22 de Outubro de 2024 | — | Declaração inicial | — | SEC |
| CPMG, INC., R. KENT MCGAUGHY, JR. | 1 de Abril de 2021 | — | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 7 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 12.849 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 7.492 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 6.653 NS | 30 de Abril de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1.000 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 41.589 SH | 8 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 118.992 SH | 8 de Agosto de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,00% | 1.385 NS | 30 de Abril de 2026 | N-PORT |